Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

War on Cancer /
Tackling increasing prevalence of cancer and treatment costs

20th Oct 2015

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 29.10.15
Views: 2187

Dr Vivek Muthu - Chief Health Advisor, The Economist Intelligence Unit

Dr Muthu talks to ecancertv at the War On Cancer Meeting about the importance of the meeting in tackling the economic burden of cancer.

As well as the loss of economic productivity, he also notes the rising costs of cancer drugs. Whilst cancer's status as a chronic disease is a "testament to the successes of healthcare", it does mean that people are more costly to look after, he explains.

He argues that there is a "huge inequality of access" to care and that more needs to be done to make sure everyone is treated appropriately within the confines of a limited budget.

Prevention is neglected, he says, and needs to be considered for economic reasons as well as for the sake of people's wellbeing.



Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation